Drugs / Ganoderma Spore Lipids
last change May 2017 re-read 3 minutes ago

Ganoderma Spore Lipids

Developed for
digestive system neoplasm
Investigated by
Xiaonan Cui

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02785523 May 2016 → May 2017 digestive system neoplasm Xiaonan Cui Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ganoderma Spore Lipids ClinicalTrials.gov intervention name — accepted as the source's own label NCT02785523 ↗